ResearcherInner Mongolia Medical UniversityActive in the last 2 years

Qian Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-5719-2634; OpenAlex author ID A5100401720. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Targeting AGTPBP1 inhibits pancreatic cancer progression via regulating microtubules and ERK signaling pathway. Co-author DOI 10.1186/s10020-024-00892-x ↗
Circular RNA expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2019.10624 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ding-zhong Li · 1 shared paper, 2024 · strength 0.23
- Paper Targeting AGTPBP1 inhibits pancreatic cancer progression via regulating microtubules and ERK signaling pathway. DOI 10.1186/s10020-024-00892-x ↗
Rui Xiao · 1 shared paper, 2024 · strength 0.23
- Paper Targeting AGTPBP1 inhibits pancreatic cancer progression via regulating microtubules and ERK signaling pathway. DOI 10.1186/s10020-024-00892-x ↗
Jian-jun Ren · 1 shared paper, 2024 · strength 0.23
- Paper Targeting AGTPBP1 inhibits pancreatic cancer progression via regulating microtubules and ERK signaling pathway. DOI 10.1186/s10020-024-00892-x ↗
Shan Zhong · 1 shared paper, 2019 · strength 0.12
- Paper Circular RNA expression in pancreatic ductal adenocarcinoma. DOI 10.3892/ol.2019.10624 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.